Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Workers at Pfizer Australian manufacturing site the latest to walk out in labor dispute protests
Endpoints
Tue, 08/9/22 - 11:52 pm
Tags:
Pfizer, Australia, labor disputes
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
BioSpace
Tue, 08/9/22 - 06:27 am
Tags:
Pfizer, Valneva, clinical trials, vaccines, Lyme disease, VLA15
Pfizer and Myovant’s endometriosis pain drug Myfembree gets another FDA nod
Endpoints
Mon, 08/8/22 - 11:28 pm
Tags:
Pfizer, Myovant, FDA, Myfembree, endometriosis
Pfizer buys sickle cell drugmaker Global Blood for $5.4B
BioPharma Dive
Mon, 08/8/22 - 10:29 am
Tags:
Pfizer, Global Blood Therapeutics, M&A, sickle cell disease, Oxbryta
Pfizer, riding high on COVID windfall, eyes $5B play for Global Blood Therapeutics
Fierce Pharma
Sun, 08/7/22 - 11:27 pm
Tags:
Pfizer, Global Blood Therapeutics, M&A, Oxbryta
Alnylam drug succeeds in heart study, setting stage for FDA filing and showdown with Pfizer
MedCity News
Thu, 08/4/22 - 11:09 am
Tags:
Alnylam, Pfizer, Onpattro, hATTR
Pfizer to discontinue Phase III dilated cardiomyopathy trial
Clinical Trials Arena
Thu, 08/4/22 - 10:58 am
Tags:
Pfizer, clinical trials, dilated cardiomyopathy, PF-07265803
July Brings Layoffs, Job Creation for the Life Sciences
BioSpace
Wed, 08/3/22 - 09:32 pm
Tags:
layoffs, hirings, Astellas, Pfizer, Eikon Therapeutics, Bayer, Avadel Pharma, Heron Therapeutics, Adverum Biotechnologies, Biogen, Eisai, X4 Pharmaceuticals, Assembly Biosciences
Racing Merck and Pfizer, Roche readies to file subcutaneous Tecentriq after posting phase 3 data
Fierce Pharma
Tue, 08/2/22 - 10:54 am
Tags:
Roche, Pfizer, Merck, Tecentriq, clinical trials, cancer, checkpoint inhibitors
Why Pfizer and BioNTech Are Beating Moderna in the Omicron Booster Market
Motley Fool
Tue, 08/2/22 - 10:32 am
Tags:
Pfizer, BioNTech, Moderna Therapeutics, vaccines, COVID-19, boosters, government contract
Pfizer sales of COVID-19 vaccine, pill beat forecasts as company prepares for future waves
BioPharma Dive
Thu, 07/28/22 - 12:27 pm
Tags:
Pfizer, earnings, Paxlovid, vaccines, COVID-19
The NASH curse strikes again. Pfizer dumps early-stage asset for liver condition
Fierce Biotech
Thu, 07/28/22 - 11:08 am
Tags:
Pfizer, PF-06882961, NASH
Pfizer and BioNTech Push Hard on Omicron-Specific Vaccine While Fending Off Lawsuits
BioSpace
Wed, 07/27/22 - 10:47 am
Tags:
Pfizer, BioNTech, COVID-19, vaccines, boosters, patents, CureVac
Pfizer loses court battle to keep its Vyndaqel copay assistance for Medicare patients—again
Fierce Pharma
Tue, 07/26/22 - 05:23 pm
Tags:
Pfizer, copay asssistance programs, Vyndaqel, Medicare, kickbacks
Pfizer, BioNTech rebuff CureVac's 'groundless' patent infringement claims against COVID-19 shot Comirnaty
Fierce Pharma
Tue, 07/26/22 - 11:23 am
Tags:
Pfizer, BioNTech, COVID-19, CureVac, vaccines, patents
Pfizer's Paxlovid sales will top at $30B this year then fall over time: analysts
Fierce Pharma
Fri, 07/22/22 - 10:13 am
Tags:
Pfizer, Paxlovid, antivirals, COVID-19
Pfizer, Flynn Pharma slapped with £70 million fine for massive price hike on epilepsy drug
Fierce Pharma
Thu, 07/21/22 - 09:38 pm
Tags:
Pfizer, Flynn Pharma, antitrust, drug pricing, Epanutin
Staffing shortage could be hindering controversial Paxlovid clearance
Beckers Hospital Review
Thu, 07/21/22 - 09:35 pm
Tags:
Pfizer, Paxlovid, COVID-19, antivirals, FDA, pharmacists
Pfizer, Gilead and others seek clarifications on trial designs outlined in FDA's UC and Crohn's draft guidance
Endpoints
Thu, 07/21/22 - 10:38 am
Tags:
Pfizer, Gilead Sciences, Big Pharma, ulcerative colitis, Crohn's Disease, drug development, FDA
Pfizer to make major investment in vaccine R&D and manufacturing site in New York
Endpoints
Thu, 07/21/22 - 10:32 am
Tags:
Pfizer, New York, R&D, vaccines

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.